Ryan P. Manger

Ryan P. Manger

Auto-generated profile, based on publicly available information

Ryan P. Manger

UC San Diego Radiation Medicine and Applied Sciences, 3855 Health Sciences Dr. #0843, La Jolla, CA, 92093-0843, USA.

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2016 in Annals of the ICRP
Verified
Journal Article
Closed access
WBW.E. Bolch
W.E. Bolch
DJD. Jokisch
D. Jokisch
MZM. Zankl
M. Zankl
KEK.F. Eckerman
K.F. Eckerman
TFT. Fell
T. Fell
NPN. Petoussi-Henss
N. Petoussi-Henss
Dose coefficients for assessment of internal exposures to radionuclides are radiological protection quantities giving either the organ equivalent dose or effective dose per intake of radionuclide following ingestion or inhalation. In the International Commission on Radiological Protection’s (ICRP) Occupational Intakes of Radionuclides (OIR) publication series, new biokinetic models for distribution of internalised radionuclides in the human body are presented as needed for establishing time-integrated activity within organs of deposition (source regions). This series of publications replaces Publications 30 and 68 (ICRP, 1979, 1980, 1981, 1988, 1994b). In addition, other fundamental data needed for computation of the dose coefficients are radionuclide decay data (energies and yields of emitted radiations), which are given in Publication 107 (ICRP, 2008), and specific absorbed fraction (SAF) values – defined as the fraction of the particle energy emitted in a source tissue region that is deposited in a target tissue region per mass of target tissue. This publication provides the technical basis for SAFs relevant to internalised radionuclide activity in the organs of Reference Adult Male and Reference Adult Female as defined in Publications 89 and 110 (ICRP, 2002, 2009). SAFs are given for uniform distributions of mono-energetic photons, electrons, alpha particles, and fission-spectrum neutrons over a range of relevant energies. Electron SAFs include both collision and radiative components of energy deposition. SAF data are matched to source and target organs of the biokinetic models of the OIR publication series, as well as the Publication 100 (ICRP, 2006) Human Alimentary Tract Model and the Publication 66 (ICRP, 1994a) Human Respiratory Tract Model, the latter as revised within Publication 130 (ICRP, 2015). This publication further outlines the computational methodology and nomenclature for assessment of internal dose in a manner consistent with that used for nuclear medicine applications. Numerical data for particle-specific and energy-dependent SAFs are given in electronic format for numerical coupling to the respiratory tract, alimentary tract, and systemic biokinetic models of the OIR publication series.

26 February 2016 in Medical Physics
Verified
Journal Article
Open access
PDF file
TPTodd Pawlicki
Todd Pawlicki
ASAubrey Samost
Aubrey Samost
DBDerek W. Brown
Derek W. Brown
RMRyan P. Manger
Ryan P. Manger
GKGwe‐Ya Kim
Gwe‐Ya Kim
NLNancy G. Leveson
Nancy G. Leveson
Purpose: Both humans and software are notoriously challenging to account for in traditional hazard analysis models. The purpose of this work is to investigate and demonstrate the application of a new, extended accident causality model, called systems theoretic accident model and processes (STAMP), to radiation oncology. Specifically, a hazard analysis technique based on STAMP, system‐theoretic process analysis (STPA), is used to perform a hazard analysis.Methods: The STPA procedure starts with the definition of high‐level accidents for radiation oncology at the medical center and the hazards leading to those accidents. From there, the hierarchical safety control structure of the radiation oncology clinic is modeled, i.e., the controls that are used to prevent accidents and provide effective treatment. Using STPA, unsafe control actions (behaviors) are identified that can lead to the hazards as well as causal scenarios that can lead to the identified unsafe control. This information can be used to eliminate or mitigate potential hazards. The STPA procedure is demonstrated on a new online adaptive cranial radiosurgery procedure that omits the CT simulation step and uses CBCT for localization, planning, and surface imaging system during treatment.Results: The STPA procedure generated a comprehensive set of causal scenarios that are traced back to system hazards and accidents. Ten control loops were created for the new SRS procedure, which covered the areas of hospital and department management, treatment design and delivery, and vendor service. Eighty three unsafe control actions were identified as well as 472 causal scenarios that could lead to those unsafe control actions.Conclusions: STPA provides a method for understanding the role of management decisions and hospital operations on system safety and generating process design requirements to prevent hazards and accidents. The interaction of people, hardware, and software is highlighted. The method of STPA produces results that can be used to improve safety and prevent accidents and warrants further investigation.

7 November 2016 in Medical Physics
Verified
Journal Article
Open access
JRJeong‐Eun Rah
Jeong‐Eun Rah
RMRyan P. Manger
Ryan P. Manger
AYAdam D. Yock
Adam D. Yock
GKGwe‐Ya Kim
Gwe‐Ya Kim
Purpose: To examine the abilities of a traditional failure mode and effects analysis (FMEA) and modified healthcare FMEA (m‐HFMEA) scoring methods by comparing the degree of congruence in identifying high risk failures.Methods: The authors applied two prospective methods of the quality management to surface image guided, linac‐based radiosurgery (SIG‐RS). For the traditional FMEA, decisions on how to improve an operation were based on the risk priority number (RPN). The RPN is a product of three indices: occurrence, severity, and detectability. The m‐HFMEA approach utilized two indices, severity and frequency. A risk inventory matrix was divided into four categories: very low, low, high, and very high. For high risk events, an additional evaluation was performed. Based upon the criticality of the process, it was decided if additional safety measures were needed and what they comprise.Results: The two methods were independently compared to determine if the results and rated risks matched. The authors’ results showed an agreement of 85% between FMEA and m‐HFMEA approaches for top 20 risks of SIG‐RS‐specific failure modes. The main differences between the two approaches were the distribution of the values and the observation that failure modes (52, 54, 154) with high m‐HFMEA scores do not necessarily have high FMEA‐RPN scores. In the m‐HFMEA analysis, when the risk score is determined, the basis of the established HFMEA Decision Tree™ or the failure mode should be more thoroughly investigated.Conclusions: m‐HFMEA is inductive because it requires the identification of the consequences from causes, and semi‐quantitative since it allows the prioritization of high risks and mitigation measures. It is therefore a useful tool for the prospective risk analysis method to radiotherapy.

1 May 2015 in Medical Physics
Verified
Journal Article
Closed access
RMRyan P. Manger
Ryan P. Manger
APAdam B. Paxton
Adam B. Paxton
TPTodd Pawlicki
Todd Pawlicki
GKGwe‐Ya Kim
Gwe‐Ya Kim

3 September 2019 in Radiation Oncology
Verified
Journal Article
Open access
PDF file
DHDavid Hoffman
David Hoffman
IDIrena Dragojević
Irena Dragojević
JHJeremy Hoisak
Jeremy Hoisak
DHDavid Hoopes
David Hoopes
RMRyan Manger
Ryan Manger
The treatment of lung lesions with stereotactic body radiation therapy calls for highly conformal dose, which is evaluated by a number of metrics. Lung stereotactic body radiation therapy clinical trials constrain a plans gradient index. The purpose of this work is to describe the dependence of clinically achievable dose gradient on planning target volume. Three hundred seventy-four lung stereotactic body radiation therapy treatment plans were retrospectively reviewed and selected for this study. The relationship between R50% and planning target volume size was observed and compared against the RTOG 0915 and 0813 constraints noting minor and major deviations. Then a least squares regression was used to determine the coefficients for a power functional form of the dependence of gradient measure (GM) on planning target volume size. Of the 317 peripheral lung SBRT plans, 142 exhibited no deviation, 135 exhibited a minor deviation, and 40 exhibited a major deviation according to the RTOG 0915 dosimetric. conformality and dose fall-off constraints. A plot of gradient measure versus planning target volume size for peripheral lesions, excluding RTOG 0915 major deviations, is fit with an power function of GM = 0.564 V0.215. Using the PTV size and GM relationship we have characterized, treatment plans with PTV < 85 cm3 can be evaluated subjectively to our previously plans, and given a percentile GM. This relationship and evaluation is useful for volumetric modulated arc therapy lung stereotactic body radiation therapy treatment planning and quality control.

25 July 2016 in Journal of Applied Clinical Medical Physics
Verified
Journal Article
Open access
PDF file
RMRyan Manger
Ryan Manger
APAdam Paxton
Adam Paxton
LCLaura Cerviño
Laura Cerviño
Brass mesh bolus has been shown to be an acceptable substitute for tissue‐equivalent bolus to increase superficial dose for chest wall tangent photon radiotherapy. This work investigated the increase in surface dose, the change in the dose at depth, and the safety implications of higher energy photon beams when using brass mesh bolus for postmastectomy chest wall radiotherapy. A photon tangent plan was delivered to a thorax phantom, and the superficial dose ranged from 40%–72% of prescription dose with no bolus. The surface dose increased to 75%–110% of prescription dose with brass mesh bolus and 85%–109% of prescription dose with tissue‐equivalent bolus. It was also found that the dose at depth when using brass mesh bolus is comparable to that measured with no bolus for en face and oblique incidence. Monte Carlo calculations were used to assess the photoneutron production from brass mesh bolus used with 15 MV and 24 MV photon beams. The effective dose from photoneutrons was approximated and found to be relatively small, yet not negligible. Activation products generated by these photoneutrons, the surface dose rate due to the activation products, and the half‐life of the activation products were also considered in this work. The authors conclude that brass mesh bolus is a reasonable alternative to tissue‐equivalent bolus, and it may be used with high‐energy beam; but one should be aware of the potential increased effective dose to staff and patients due to the activation products produced by photoneutrons.PACS number(s): 87.53.Kn, 87.55.K